We are pleased to present below all posts archived in 'February, 2014'. If you still can't find what you are looking for, try using the search box.
Northampton, UK– 24th February 2014 – HORIBA UK Ltd, Medical Division, has launched the new Pentra XLR compact 5 part DIFF haematology analyser incorporating full reticulocyte parameters to facilitate the investigation and diagnosis of haemopoiesis and anaemia. As the latest addition to the Pentra family, the XLR brings HORIBA’s gold standard reticulocyte technology with STAT capabilities to a smaller platform.
Read the rest of entry »
24th February 2014, Cobham, UK – Proteome Sciences plc (“Proteome Sciences” or the “Company”) is pleased to announce that it has conditionally placed 17,857,143 new ordinary shares of 1p each (“New Ordinary Shares”) to raise £5 million before expenses with new and existing investors (the “Placing”) at 28p per share (the “Placing Price”) to provide additional working capital for the Company.
Compared to traditional lyophilised plasma controls, the Precision BioLogic (Nova Scotia, Canada), range of CRYOcheckTM Factor Deficient Plasmas provide significant quality and productivity improvements for the haemostasis laboratory. Exclusively available in the UK from Alpha Laboratories (Hampshire, UK), these frozen, platelet-poor plasmas are immunodepleted and assayed at less than 1% for the specific factor, by functional and antigenic methods.*
7th February, 2014 - Cobham, UK. The Directors would like to update shareholders on the Company’s trading activities. Revenue for 2013 is expected to show a significant increase over 2012 resulting from the strong performance across our core activities.
Italian Voden Medical Instruments S.p.A. awarded DiaSorin Platinum Distributor status
The Milan-based Life Science Division of Voden Medical Instruments S.p.A. has been awarded DiaSorin Platinum Distributor status in recognition of their outstanding contribution to sales of the DiaSorin Arrow instrument and molecular extraction kits throughout Italy.
www.Sepsis-Diagnostics.co.uk is now live. This dedicated website developed by Alpha Laboratories provides a valuable resource regarding the serious issue of sepsis. A systemic inflammatory response to a microbial infection, sepsis occurs in 1 in 23 patients admitted to hospital and has a tragic 16% mortality rate.
EKF Diagnostics (www.ekfdiagnostics.com), the global in vitro diagnostics business, announces that its subsidiary company EKF Molecular Diagnostics is exhibiting its ground-breaking PointMan™ DNA-enrichment technology at Tri-Con 2014 in San Francisco, CA, Booth #417, 10-14th February.
Siemens Healthcare Diagnostics has announced that it has entered into a collaboration agreement with Pfizer, the world's largest research-based pharmaceutical company, to design, develop and commercialise diagnostic tests for therapeutic products across Pfizer’s pipeline.
Who are the BIVDA Members
Member Press Releases
Point of Care Directory
News, Policy and Media
BIVDA Press Releases